GlassScriptPhysician profile
Pui C Cheng
NPI 1568554319
$1,628.79
in general payments reported to CMS, 2019-2025
20 companies · $701 in 2025
The $701 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $15.56 · 2021: $34.58 · 2022: $85.44 · 2023: $328 · 2024: $359 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.36 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $337.00 | 2023-2025 | Zejula, Jemperli |
| Merck Sharp & Dohme LLC | $301.21 | 2019-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $239.47 | 2019-2025 | Lynparza, Enhertu |
| Eisai INC. | $166.77 | 2022-2025 | |
| Astellas Pharma US INC | $128.51 | 2024-2025 | Veozah |
| Abbvie INC. | $69.71 | 2021-2025 | |
| Scynexis, INC. | $62.03 | 2022 | |
| Sumitomo Pharma America, INC. | $55.04 | 2023-2025 | Myfembree |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.58 | 2024 | Gilotrif |
| Mayne Pharma Commercial LLC | $30.00 | 2025 | |
| Clovis Oncology, INC. | $28.18 | 2019-2020 | |
| Caris Mpi, INC. | $27.92 | 2025 | Mi Cancer Seek |
| Pharmaand Gmbh | $24.97 | 2025 | Rubraca |
| Myriad Genetic Laboratories, INC. | $22.04 | 2021 | |
| Immunogen, INC. | $21.66 | 2023 | Elahere |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $20.46 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.28 | 2023 | Exparel |
| Coopersurgical, INC. | $17.31 | 2025 | Ally II Ups |
| Lupin INC. | $13.74 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pui Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.